Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
7.0
7.8
Journals
Vaccines
Special Issues
HPV Vaccination Policies/Strategies
share announcement

HPV Vaccination Policies/Strategies

A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Human Vaccines and Public Health".

Deadline for manuscript submissions: closed (31 December 2023) | Viewed by 5789

Special Issue Editors

Dr. Spring Chenoa Cooper

E-Mail Website
Guest Editor
Community Health and Social Sciences, CUNY Graduate School of Public Health and Health Policy, City University of New York, New York, NY, USA
Interests: HPV; sexual health; adolescent health; vaccination; health promotion
Dr. Peter Agyei-Baffour

E-Mail Website
Guest Editor
Department of Health Policy, University of Michigan, Ann Abor, MI, USA
Interests: behavior
Dr. Raghunadharao Digumarti

E-Mail Website
Guest Editor
KIMS ICON Hospital, Visakhapatnam, India
Interests: palliative care services

Special Issue Information

Dear Colleagues,

Cervical cancer is a disease with a definite etiology, early prevention, and treatment. On 17 November 2020, the World Health Organization (WHO) launched the Global Strategy to Accelerate the Elimination of Cervical Cancer. This is the first time that 194 countries have made a joint commitment to eliminate a cancer. The HPV vaccine is considered to be the most cost-effective and effective way to prevent cervical cancer. However, the HPV vaccine does not have full coverage at present, so we should strengthen the popularization of HPV vaccine education, vaccination, and early prevention, so that more and more women of the right age can have the danger of cervical cancer removed as soon as possible. 

We welcome you to submit articles, reviews, case studies, or other types of papers discussing HPV vaccination implementation, monitoring, research, programs, improving equity in HPV vaccination, policies related to HPV vaccination, and social as well as behavioral science strategies with which to support vaccine acceptance. 

We look forward to receiving your contributions.

Dr. Spring Chenoa Cooper
Dr. Peter Agyei-Baffour
Dr. Raghunadharao Digumarti
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • vaccination
  • HPV
  • vaccine confidence
  • risk communication
  • vaccine hesitancy
  • challenges
  • cervical cancer

Published Papers (3 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

Jump to: Other

13 pages, 555 KiB  
Article
Development and Appraisal of a Web-Based Decision Aid for HPV Vaccination for Young Adults and Parents of Children in Israel—A Quasi-Experimental Study
by Yulia Gendler
Vaccines 2023, 11(6), 1038; https://doi.org/10.3390/vaccines11061038 - 29 May 2023
Cited by 1 | Viewed by 1338
Abstract
Background: This study aimed to develop and evaluate the effectiveness of two web-based decision aids designed to help parents of children aged 10–17 years and young adults aged 18–26 years make informed decisions about the HPV vaccine. Methods: The decision aids were developed [...] Read more.
Background: This study aimed to develop and evaluate the effectiveness of two web-based decision aids designed to help parents of children aged 10–17 years and young adults aged 18–26 years make informed decisions about the HPV vaccine. Methods: The decision aids were developed according to the International Patient Decision Aid Standards (IPDAS) criteria and included information about the vaccine, probabilities of benefits and side effects, personal narratives, and values clarification. The study utilized a quasi-experimental design and included 120 Hebrew-speaking parents and 160 young adults. Participants completed baseline surveys and, two weeks after using the decision aid, completed a follow-up survey. Results: Both parents and young adults experienced a reduction in decisional conflict, an increase in self-efficacy, and greater confidence in the safety and effectiveness of the vaccine. The proportion of participating parents deciding to vaccinate their children against HPV increased from 46% to 75%, and the proportion of participating young adults leaning towards receiving the HPV vaccine increased from 64% to 92%. Conclusions: The study highlights the importance of using decision aids to support informed decision making about vaccination and suggests that web-based decision aids may be a useful tool for supporting Israeli parents and young adults to make HPV vaccination decisions. Full article
(This article belongs to the Special Issue HPV Vaccination Policies/Strategies)
►▼ Show Figures

Figure 1

Other

Jump to: Research

12 pages, 667 KiB  
Systematic Review
Recommended Interventions to Improve Human Papillomavirus Vaccination Uptake among Adolescents: A Review of Quality Improvement Methodologies
by Karniza Khalid, Kun Yun Lee, Nur Farihan Mukhtar and Othman Warijo
Vaccines 2023, 11(8), 1390; https://doi.org/10.3390/vaccines11081390 - 21 Aug 2023
Cited by 1 | Viewed by 1201
Abstract
Background: Routine human papillomavirus (HPV) vaccine uptake continues to be suboptimal since its recommendation in 2006 for girls and in 2011 for boys. This paper aims to review published quality improvement (QI) methodologies on interventions to improve HPV vaccine uptake among adolescents. Methods: [...] Read more.
Background: Routine human papillomavirus (HPV) vaccine uptake continues to be suboptimal since its recommendation in 2006 for girls and in 2011 for boys. This paper aims to review published quality improvement (QI) methodologies on interventions to improve HPV vaccine uptake among adolescents. Methods: Science Direct and Scopus databases were searched for QI initiatives evaluating the effect of multimodal interventions to improve HPV vaccination rates (initiation and/or completion of series) among adolescents. Studies that included an outcome of interest among adolescents aged 10 to 18 years old were included. Two investigators worked independently to screen for potential articles and a designated investigator extracted data on study characteristics and evaluated the outcomes. Results: A preliminary search yielded a total of 523 articles and 13 were included in the final analysis. Common strategies were provider-specific (i.e., webinar, telementoring, train-the-trainer approach) and patient- and/or parent-specific interventions (i.e., reminder emails, phone calls and text messages, social events), with an emphasis on education and knowledge empowerment. System-level interventions such as policy changes and revised protocols were less commonly prescribed despite being associated with a more significant weight on the overall outcome. Conclusions: Creative, sustainable, and economical multilevel interventions that focus not only on provider training and public education but also incorporate local policies and system enhancements can substantially improve HPV vaccination coverage among adolescents. Full article
(This article belongs to the Special Issue HPV Vaccination Policies/Strategies)
►▼ Show Figures

Figure 1

14 pages, 1063 KiB  
Systematic Review
HPV Vaccination Adherence in Working-Age Men: A Systematic Review and Meta-Analysis
by Carlotta Amantea, Nazario Foschi, Filippo Gavi, Ivan Borrelli, Maria Francesca Rossi, Valerio Spuntarelli, Pierluigi Russo, Maria Rosaria Gualano, Paolo Emilio Santoro and Umberto Moscato
Vaccines 2023, 11(2), 443; https://doi.org/10.3390/vaccines11020443 - 15 Feb 2023
Cited by 4 | Viewed by 2787
Abstract
Background: Human papillomavirus (HPV) infection is the most common sexually transmitted viral infection in the world. HPV vaccination adherence rates in men are generally lower than in women. The aim of this systematic review and meta-analysis was to assess adherence to HPV vaccination [...] Read more.
Background: Human papillomavirus (HPV) infection is the most common sexually transmitted viral infection in the world. HPV vaccination adherence rates in men are generally lower than in women. The aim of this systematic review and meta-analysis was to assess adherence to HPV vaccination in young working-age males (18–30 years old). Methods: A systematic review was performed using three databases: PubMed, Scopus, and Web of Science, according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Results: After duplicate removal, the initial search resulted in 478 eligible papers. With the exclusion of 425 papers after screening the abstracts, full texts of 53 articles were reviewed. Subsequently, 45 were excluded. Among the eight studies included, four (50%) examined the vaccination adherence in young adults through data registered in nationwide insurance or private companies’ databases, three (37.5%) in young adults in different settings through data collected from surveys and questionnaires, and one (12.5%) an HPV vaccination campaign in a family medicine residency practice. Conclusion: Adherence to HPV vaccination in men of working age (18–30 years) does not appear to be adequate (pooled prevalence 11%). In order to achieve a higher level of compliance, it is important to place an emphasis on vaccination campaigns in schools as well as in the workplace, after consultation with and approval from local, regional, and federal public health agencies. Full article
(This article belongs to the Special Issue HPV Vaccination Policies/Strategies)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-3
Back to TopTop